When a BioTech or Life Sciences company goes public, change is inevitable. At this presentation, you will learn how the HR department can help the company succeed during the transition.

During the April meeting for the HR BioTech Connect event, we will discuss a very timely topic — that is, what happens when a BioTech or Life Sciences company goes public. Over the course of the last 18 months, Radford has supported more than 25 IPOs in the Life Sciences sector. Each company brought with it a unique set of challenges and opportunities relating to timing, company constraints, compensation philosophy, equity planning, and pay actions considered headed into the IPO. Radford will facilitate a panel of your peers sharing our collective experience by discussing the process; some of the “wins” and sticking points along the way (both internally and at the Comp Committee level); and the new set of challenges facing these newly public companies. These challenges will include introducing more structure in broader employee cash and equity programs, developing policies for delegation of authority in equity granting practices, reinforcing good governance habits at the Compensation Committee level and managing employee communications in a public company environment. We look forward to seeing you at this meeting for HR BioTech Connect members.